Table 1 Patients’ demographic and main clinical baseline characteristics.
From: Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis
Mean | Range | |
|---|---|---|
Age (years) | 60.74 | 29–84 |
N | Percentage (%) | |
Sex (M/F) | 60/29 | 67.4/32.6 |
Etiology of liver cirrhosis | N | Percentage (%) |
Alcohol consumption | 32 | 36.4 |
HBV ± HDV infection | 29 | 32.5 |
HCV infection | 10 | 10.4 |
Cryptogenic cirrhosis | 6 | 6.5 |
Autoimmune hepatitis | 5 | 5.2 |
Primary biliary cirrhosis | 3 | 3.9 |
Nonalcoholic steatohepatitis | 2 | 2.6 |
Primary sclerosing cholangitis | 1 | 1.3 |
HBV infection + HCV infection | 1 | 1.3 |
Median (IQR) | ||
Vitamin D levels (ng/mL) | 21.1 (14.7, 31.6) | |
Hb (g/dL) | 12.7 (11.2, 13.8) | |
Plt (K/uL) | 117.5 (66, 160) | |
INR | 1.3 (1.1, 1.6) | |
Creatinine (mg/dL) | 0.9 (0.7, 1.1) | |
SGPT (U/L) | 31.0 (21.0, 58.0) | |
G-GT (U/L) | 54.0 (29.0, 109.0) | |
ALP (U/L) | 101.5 (76.0, 142.0) | |
Albumin (g/dL) | 3.6 (3.0, 4.0) | |
Total Bilirubin (mg/dL) | 1.3 (0.7, 2.5) | |
K (mmol/L) | 4.3 (3.9, 4.7) | |
Na (mmol/L) | 138.4 (135.2, 141.0) | |
Ca (mmol/L) | 9.0 (8.6, 9.4) | |
Mg (mmol/L) | 1.9 (1.6, 2.1) | |
Systolic pressure (mmHg) | 130.0 (115.0, 150.0) | |
Diastolic pressure (mmHg) | 75.0 (70.0, 80.0) | |
CP score | 6.0 (5.0, 9.0) | |
MELD | 11.0 (8.0, 15.5) | |
VDBP (µg/mL) | 160.8 (99.3, 257.9) | |
IL-12 (pg/mL) | 7.5 (2.1, 8.7) | |
TNF-a (pg/mL) | 4.7 (1.2, 5.7) | |
IL-1β (pg/mL) | 8.0 (3.1, 11.6) | |
IL-6 (pg/mL) | 7.8 (4.3, 22.0) | |
IL-8 (pg/mL) | 35.7 (20.6, 90.7) | |
IL-10 (pg/mL) | 3.9 (3.1, 4.7) | |
LBP (μg/mL) | 10.8 (8.3, 11.4) | |
